Skip to main content
. 2013 Aug 16;9(12):2505–2523. doi: 10.4161/hv.26109

Table 3. N mening conjugate C, A and A + C vaccine studies.

Reference Authors Year Published Vaccine Population Country Study Design
149 Fairley, Begg, Borrow et al. 1996 Men A and C-CRM197 Infants UK S and I
82 Leach, Twumasi, Kumah et al. 1997 Men A + C-CRM197 Children The Gambia Immune Memory
83 MacDonald, Halperin, Law et al. 1998 Men C-CRM197 Toddlers Canada Immune Memory
84 Richmond, Borrow, Miller et al. 1999 Men C-CRM197 Infants UK S and I
85 MacLennan, Shackley, Heath et al. 2000 Men C-CRM Infants UK S and I and Immune Memory
150 Campagne, Garba, Fabre et al. 2000 Men A + C-D Infants Niger S and I
153 Zhang, Lakshman, Burkinshaw et al. 2001 Men A + C-CRM197 Adolescents/Adults UK Mucosal I
86 Richmond, Borrow, Goldblatt et al. 2001 Men C – T/CRM197 Toddlers UK Immune Memory
87 MacLennen, Obaro, Deeks et al. 2001 Men A + C-CRM197 Children The Gambia Immune Memory
151 Miller, Salisbury, Ramsay et al. 2001 Men C – T/CRM197 Children/Adults UK Effectiveness
152 Ramsay, Andrews, Kaczmarski et al. 2001 Men C – T/CRM197 Toddlers/Adolescents UK Effectiveness
154 Rennels, Edwards, Keyserling et al. 2001 Men C-CRM197 Infants USA S and I
88 Borrow, Goldblatt, Andrews et al. 2002 Men C-CRM197 Children UK Immune Memory
89 McVernon, MacLennan, Buttery et al. 2002 Men C-CRM197 Infants/Children UK S and I
155 Joseph, Ryall and Bybel et al. 2003 Men A + C-D Children UK I + Immune Memory
135 De Wals, Deceuninck, Boulianne et al. 2004 Men C-CRM197 Infants to Adults Canada Effectiveness
136 Trotter, Andrews, Kaczmrski et al. 2004 Men C – T/CRM197 Infants to Adolescents UK Effectiveness
156 De Wals, Deceuninck, De Serres et al. 2005 Men C-CRM197 Children/Adolescents Canada Effectiveness
157 Gray, Trotter, Ramsay et al. 2006 Men C – T/CRM197 Children/Adolescents UK Effectiveness
158 de Greeff, de Melker, Spanjaard et al. 2006 Men C-T Toddlers Netherlands Effectiveness
159 Snape, Kelly, Salt et al. 2006 Men C-CRM197 Adolescents UK Immune Memory
160 Trotter, Chandra, Cano et al. 2007 Men C – T/CRM197 Children/Adolescents Europe Effectiveness
161 Kshirsagar, Mur, Thatte et al. 2007 Men A-T Adults India S and I
162 Maiden, Ibarz-Pavon, Urwin et al. 2008 Men C – T/CRM197 Adolescents UK Efficacy on NP carriage
163 Bettinger, Scheifele, Le Saux et al. 2009 Men C-CRM197 Infants to Adults Canada Effectiveness
164 De Wals, Deceuninck, Lefebvre et al. 2011 Men C-CRM197 Infants to Adults Canada Effectiveness

S, Safety; I, Immunogenicity; E, Efficacy.